谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Palbociclib (P) in Patients (pts) with Head and Neck Cancer (HNC) with CDKN2A Loss or Mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Evan P. Pisick,Michael Rothe,Pam K. Mangat,Liz Garrett-Mayer,Francis P. Worden,Jessica R. Bauman,Siqing Fu,Rom S. Leidner,Ani Sarkis Balmanoukian,Carmen Calfa,Daniel R. Carrizosa,Stacy D. D'Andre,Lisle Nabell,Min S. Park,Steven Francis Powell,Ramya Thota,Richard L. Schilsky

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 7|浏览30
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要